olfactory receptor family 7 subfamily E member 24Genealiases: HSHT2 · OR19-8 · OR7E24P · OR7E24Q
Q-omics provides the consensus-scored OR7E24 profile across patient tissues and cancer cell-line models. OR7E24 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, OR7E24 is differentially expressed in 4, with the highest sampling consensus in KIRC. Additionally, OR7E24 RNA expression shows 10,366 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight BLCA, KIRC, and TGCT as cancer lineages where OR7E24 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR7E24 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR7E24 survival associations across molecular data types. OR7E24 RNA expression shows survival associations in the most cancer types (17), followed by mutation status (4). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR7E24 RNA expression–survival associations across cancer types. High OR7E24 expression shows unfavorable associations in BLCA, OV, UVM and LUSC, but favorable associations in UCS and SKCM. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify BLCA as the clearest survival context for OR7E24 RNA expression.
This table summarizes OR7E24 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for OR7E24. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR7E24 shows higher tumor expression in KIRC, KIRP, COAD and THCA. The KIRC box plot shows higher OR7E24 RNA expression in tumor versus normal tissue (log2 FC = +0.007, t-test p = .007).
This table shows molecular features associated with OR7E24 in patient tissues and cancer cell lines. In patient samples, OR7E24 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set. In cancer cell lines, OR7E24 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD, while CRISPR and shRNA rows add functional-dependency signals in SKIN and LARGE_INTESTINE.
